Back
Speaker illustration

Doctor Thomas Adam Agbaedeng

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Dr Agbaedeng is postdoctoral fellow at the Centre for Heart Rhythm Disorders, The University of Adelaide. Dr Agbaedeng has a broad research interest in drivers of cardiac fibrillation and arrhythmias. He pursues a mechanistic line of research, which incorporates animal models, ex vivo models, molecular biology techniques, biochemical, and histological methods to decipher factors contributing to abnormal cardiac remodelling.

Presentations Articles

Fibrosis detected by late-gadolinium enhancement cardiac MRI is associated with atrial fibrillation and poorer ablation outcome: A meta-analysis

Event: ESC Congress 2019

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Epidemiology of atrial fibrillation

Access
Like
Thumbnail

Weight fluctuation demonstrates residual atrial arrhythmogenic substrate despite final weight loss in a chronic sheep model: implications for epicardial fat and fibrofatty infiltrates

Event: ESC Congress 2019

Topic: Arrhythmias

Session: Insight into atrial physiology and pathology

Access
Like
Thumbnail

Ventricular structural remodelling in an ovine sheep model of sustained weight gain: Potential role of desmoglein-2 in fibro-fatty replacement and arrhythmogenicity

Event: EHRA 2018

Topic: Ventricular Arrhythmias and SCD - Pathophysiology and Mechanisms

Session: Young Investigator Awards - Basic Science

Access
Like
Thumbnail

Risk of sudden cardiac death in obesity: A systematic review and meta-analysis of emerging evidence

Event: ESC Congress 2017

Topic: Risk scores

Session: Lipids, obesity and metabolic syndrome

Access
Like
Thumbnail

Effects of epicardial fat and anterior fat pad removal on post-operative atrial fibrillation: a systematic review and meta-analysis

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources